June 18, 2013
Merck & Co. Inc., a Bristol-Myers Squibb Co. subsidiary and Eli Lilly & Co. were all targeted by a New York product liability suit Friday alleging they concealed a link between certain diabetes drugs currently under regulatory investigation and the risk for pancreatic cancer.